Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The overall objective of this study is to continue to improve the cure rate of childhood
acute lymphoblastic leukemia (ALL) in Singapore and Malaysia in the context of a multi-centre
cooperative trial using a risk-stratified therapy based primarily on early response to
therapy utilizing a simplified minimal residual disease (MRD-lite) platform.